• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )

    3.430 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Biora Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions
    An average bioavailability of 37% for a GLP-1 receptor agonist was achieved in animals 
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Recap: Biora Therapeutics Q1 Earnings
    Via Benzinga
    Earnings Preview: Biora Therapeutics
    Via Benzinga
    Biora Therapeutics Earnings Perspective: Return On Invested Capital
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic... 
    Via Benzinga
    Dow Surges 100 Points; US Inflation Rate Drops In May
    U.S. stocks traded higher this morning, with Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.32% to 34,173.85 while the NASDAQ rose 0.72% to... 
    Via Benzinga
    Earnings Preview For Biora Therapeutics
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
    These biotech stocks with high return potential are poised to provide quick returns for investors who invest over the next year. 
    Via InvestorPlace
    Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    What Does Biora Therapeutics' Debt Look Like?
    Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) moved lower by 46.87%. When understanding a companies price change over a time period like 3 months, it could be helpful to... 
    Via Benzinga
    Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
    Preclinical data demonstrate potential to orally deliver peptides and monoclonal antibodies at bioavailability levels more than double the company’s current target 
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform
    Average bioavailability greater than 50% with high consistency observed in animal study 
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    10 Short Squeeze Candidates To Watch This Week: Getty Images, PaxMedica And This Meme Stock Retailer
    Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
    Via Benzinga
    Biora Therapeutics' Debt Overview
    Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) decreased by 61.54%. When understanding a companies price change over a time period like 3 months, it could be helpful to... 
    Via Benzinga
    Biora Therapeutics Presents Data from Device Performance Study with Repeat Doses in Both Fasted and Fed States at Crohn’s & Colitis Congress
    Study demonstrates targeted delivery devices functioned as designed when administered with food, potentially enabling non-fasted administration 
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.